| Diagnosis, management, and treatment of hepatitis C: An update# MG Ghany, DB Strader, DL Thomas, LB Seeff Hepatology 49 (4), 1335-1374, 2009 | 4445 | 2009 |
| Natural history of chronic hepatitis C LB Seeff Hepatology 36 (5B), s35-s46, 2002 | 2797* | 2002 |
| Diagnosis, management, and treatment of hepatitis C DB Strader, T Wright, DL Thomas, LB Seeff Hepatology 39 (4), 1147-1171, 2004 | 2573 | 2004 |
| An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases MG Ghany, DR Nelson, DB Strader, DL Thomas, LB Seeff Hepatology 54 (4), 1433-1444, 2011 | 1583 | 2011 |
| Pathogenesis, natural history, treatment, and prevention of hepatitis C TJ Liang, B Rehermann, LB Seeff, JH Hoofnagle Annals of internal medicine 132 (4), 296-305, 2000 | 1226 | 2000 |
| Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome HJ Alter, LB Seeff Seminars in liver disease 20 (01), 0017-0036, 2000 | 1139 | 2000 |
| 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus H Masur, JE Kaplan, KK Holmes, BL Alston, N Ampel, JR Anderson, ... Clinical Infectious Diseases 30, S29-S65, 2000 | 962* | 2000 |
| Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy: a double blind controlled trial HO Conn, CM Leevy, ZR Vlahcevic, JB Rodgers, WC Maddrey, L Seeff, ... Gastroenterology 72 (4), 573-583, 1977 | 932 | 1977 |
| Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests DR Dufour, JA Lott, FS Nolte, DR Gretch, RS Koff, LB Seeff Clinical chemistry 46 (12), 2027-2049, 2000 | 902 | 2000 |
| National Institutes of Health consensus development conference statement: management of hepatitis C National Institutes of Health Hepatology 36 (1), 5, 2002 | 872* | 2002 |
| Long-term mortality after transfusion-associated non-A, non-B hepatitis LB Seeff, Z Buskell-Bales, EC Wright, SJ Durako, HJ Alter, FL Iber, ... New England Journal of Medicine 327 (27), 1906-1911, 1992 | 856 | 1992 |
| Guidelines for preventing opportunistic infections among HIV-infected persons—2002: recommendations of the US Public Health Service and the Infectious Diseases Society of America PH Masur, JE Kaplan, KK Holmes Annals of internal medicine 137 (5_Part_2), 435-478, 2002 | 849 | 2002 |
| Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease AS Lok, LB Seeff, TR Morgan, AM Di Bisceglie, RK Sterling, TM Curto, ... Gastroenterology 136 (1), 138-148, 2009 | 801 | 2009 |
| Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis JAYH HOOFNAGLE, GM DUSHEIKO, LB SEEFF, EA Jones, ... Annals of internal medicine 94 (6), 744-748, 1981 | 800 | 1981 |
| Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring DR Dufour, JA Lott, FS Nolte, DR Gretch, RS Koff, LB Seeff Clinical chemistry 46 (12), 2050-2068, 2000 | 662 | 2000 |
| Peginterferon and ribavirin for chronic hepatitis C JH Hoofnagle, LB Seeff New England Journal of Medicine 355 (23), 2444-2451, 2006 | 634 | 2006 |
| National Institutes of Health consensus development conference: management of hepatitis C: 2002 LB Seeff, JH Hoofnagle Hepatology 36, S1-S2, 2002 | 618 | 2002 |
| Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen JH Hoofnagle, LB Seeff, ZB Bales, HJ Zimmerman, ... New England Journal of Medicine 298 (25), 1379-1383, 1978 | 601 | 1978 |
| Natural history of hepatitis C DL Thomas, LB Seeff Clinics in liver disease 9 (3), 383-398, 2005 | 555 | 2005 |
| Global burden of disease (GBD) for hepatitis C Global Burden of Hepatitis C Working Group The Journal of Clinical Pharmacology 44 (1), 20-29, 2004 | 550 | 2004 |
